Quarterly Result30 May 2026, 07:03 pm
Hindustan Bio Sciences FY26 Revenue at ₹73.71 Cr
AI Summary
Hindustan Bio Sciences Ltd's Board of Directors approved the audited standalone financial results for the fourth quarter and financial year ended March 31, 2026. The company reported revenue from operations of ₹73.71 Cr for the year ended March 31, 2026, compared to ₹81.33 Cr in the previous year. The board also approved the appointment of Mr. GBK Viswanadham as the Internal Auditor for the financial year 2026-27.
Key Highlights
- Hindustan Bio Sciences' board approved audited financial results for FY26.
- Revenue from operations for FY26 stood at ₹73.71 Cr.
- GBK Viswanadham appointed as Internal Auditor for FY27.
- Audit report with unmodified opinion issued for FY26 standalone financials.
Price Impact
More from HINDBIO